Light-emitting chemical reactions (chemiluminescence, CL) and biological reactions(bioluminescence, BL) have a diverse rangeofanalytical applications butrelatively few have been adoptedby routineclinicallaboratories. Advantagesof CL and BL assays include sensitivity (attomole and sub-attomoledetectionlimits),speed (signal generatedin a few seconds and insomecasesstablefor severalhours),nonhazardousreagents,and simpleprocedures.The mostpromisingclinicalapplications are in immunoassay, protein blotting, and DNA probe assays. Chemiluminescent molecules exploited as labels include luminol, isoluminol, acridiniumesters,thioestersand sulfonamides, and phenanthridinium esters.Separationand nonseparationassays have been devised, based on isoluminol and acndiniumesterlabels.Thecombination of the amplification propertiesof an enzymeand a CL or BL detectionreactionprovidesa highlysensitiveanalytical system. Since 1983, CL and BL methods have been developedfor many enzyme labels,e.g., alkalinephosphatase, glucose-6-phosphate dehydrogenase, horseradish peroxidase, Renilla luciferase,and xanthineoxidase. Currently, the most successful enzyme assays are the enhanced CL method for a peroxidase labelinvolving a mixture of luminol, hydrogenperoxide, andan enhancer (e.g.,p-iodophenol) andthedirectCL methodforalkaline phosphatase,with an adamantyl 1,2-dioxetanephenyl phosphateas substrate.Both systemsare verysensitive (the detectionlimitfor alkalinephosphatasewhen using the dioxetanereagentis 0.001 amol) and produce longlivedlightemission(>30 mm), which is ideal for membraneapplications inwhichlightemissionisdetectedwith photographic filmor a charge-coupled devicecamera. 'Nonstandard abbreviations: AMPPD, 3-(2'-spiroadaxnantanane) -4-methoxy-4-(3"phosphoryloxy)phenyl-1,2-diozetane;BL,bioluminescence;CL,chemiluminescence;BMPPD,4-[3-(4-hydroxyl-2-methylnaphthalene-1-phosphoryl)phenyll-4-methoxyspiro(1,2-dioxetane-3,2-adamantane);
tum yield of a CL reaction (the number of photons emitted/number of molecules reacting) is generally in the range 1-10% (e.g., luminol 1%, isoluininol 0.1%), whereas for BL reactions the yields are higher, typically in the range 10-30% (e.g., Vargula luciferase/luciferin, 30%) (1). Table 1 lists the diverse applications of these reactions. BL determination of ATP forms the basis of a variety of rapid microbiological assays (e.g., detection of bacteriuria) (27) ; I, NAD ( Table 3 , scheme 23) (27) . COL, colodmetry; FL fluorometry.
BL assays require scrupulously pure reagents (e.g., water used to prepare assay reagents) because the impurities can cause a nonspecific background signal that degrades assay sensitivity. carboxamides also have been synthesized, and the latter are particularly stable labels (35) (36) (37) (44, 45) ; this produces inactive conjugates but the luciferase activity can be recovered at the end of the assay by treatment with a thiol reagent (Figure 2 ). In this way the activity of the bacterial luciferase label is protected during the assay procedure. An alternative strategy for preparing marine bacterial luciferase conjugates involves protecting the active site of the enzyme during conjugation.
This procedure was used successfluly to prepare a marine bacterial luciferase-anti-rubella IgG conjugate (45) .
Recombinant Renilla luciferase reacts with coelenterazine to produce a glow of light at 480 nm (47) . Alter- site of attachment for antigens and antibodies. However, the CL quantum yield of luminol is reduced 10-fold when this amino group is substituted, thus reducing its specific activity (74) . Isoluminol has a CL quantum yield one-tenth that of luminol, but substitution of the aryl amino group increases the quantum yield 10-fold. Thus, most assays have used isoluminol or isoluminol derivatives as labels. Some studies have used naphthyl (75) and benzofghi]perylene-1,2-dicarboylic acid hydrazides (95) , but these labels have not become popular.
Indicator Reactions
CL and BL are used extensively to detect conventional labels, particularly enzymes, and in all cases the luminescent assay has superior sensitivity to other types of assay of the label (see Table 2 ).
Alkaline phosphat.ase.
The BL assay of alkaline phosphatase is based on a firefly D-luciferin-O-phosphate according to the scheme shown in Table 3 . Alkaline phosphatase cleaves the phosphate group to liberate D-luciferin, which, unlike the phosphate, is a substrate for the BL firefly luciferase reaction (60, 61).
Several CL assays of alkaline phosphatase now exist. The most sensitive and widely investigated involves an atanisrntyl 1,2-dioxetane aryl phosphate, which is dephosphorylated to a phenoxide intermediate that decomposes to form adnmfintanone and an aryl ester (the emitter) (Figure 1) (25,50,51) .
The light emission (477 nm) is in the form of a glow, which persists for >1 h. (53) . Recently, a second generation of dioxetane substrates has appeared in which a 5-substituent on the adnmnntyl ring serves to prevent aggregation of these molecules (54) . This reduces reagent background caused by thermal degradation and considerably improves the signal-to-background ratio for alkaline phosphatase detection (Table 5) .
Alkaline phosphatase can also be assayed by using ascorbic acid 2-0-phosphate.
This substrate is dephosphorylated to form ascorbic acid, which is detected by use of the CL lucigenin reaction (22) . Another assay involving a CL lucigenin indicator reaction has been described in the patent literature (96). In that assay, a conventional alkaline phosphatase substrate, e.g., p-nitrophenyl phosphate, is dephosphorylated, and the resulting change in the pH of the reaction mixture, caused by the release of phosphate, is detected chemiluminescently with a mixture of lucigen in ethanol and a reducing agent (mannose); the light emission from this reaction is long-lived,
>50 mm.
Several coupled enzyme reactions with either CL or BL end points have been developed for alkaline phosphatase. The principles of these assays are illustrated in Table 3 (27) .
The enhanced chemiluminescent assay of HRP (see below) can be adapted for detection of alkaline phosphatase (55 16 (63) .
Cofactors. APP and NAD conjugates can be used in immunoassays (99). APP labels are detected directly by use of the BL firefly luciferase-luciferin reaction (62) . In contrast, NAD labels must first be converted to NADH in the presence of ethanol and alcohol dehydrogenase (EC 1.1.1.1); then the NADH is measured by use of the BL marine bacterial luciferase reaction (82) . A disadvantage of cofactor-labeling strategies is the complex chemical procedures needed to link the cofactor to other molecules.
Another strategy is to use polyriboadenylic acid as a label. This has been applied to a DNA probe and the labeled probe detected by a sequential reaction with polynucleotide phosphorylase (EC 2.7.7.8). This releases ADP molecules, which are converted to APP by pyruvate kinase; the APP is measured by using the BL firefly luciferase-luciferin reaction (100) . Fluorescein. This label can be quantified by using a CL hypochiorite reaction (64) . The fluorescein label acts as an efficient emitter in an energy-transfer process and is chemically unchanged by the reaction. An assay of rubella antibody in serum showed good analytical char- based on glucose-6-phosphate dehydrogenase are discussed later.
Glucose oxidase. A CL assay of this enzyme has been devised according to the scheme shown in Table 3 .
Hydrogen peroxide produced by the label is detected by using the CL microperoxidase-catalyzed isoluminol reaction (103) . A CL peroxylate reaction can also be used to detect the hydrogen peroxide produced by the action of this enzyme (66).
Horseradish peroixidase. HRP catalyzes the CL oxidation of cyclic diacyihydrazides such as luminol, a reacti#{243}n that has been used to measure HRP activity (104) . Addition of small amounts of certain phenols, naphthols, and amines Cenhancers") improves the analytical features of this reaction (70, 71) . p-Iodophenol, p-phenyiphenol, and p-hydroxycinnRmic acid have been the most widely used enhancers. In an enhanced CL reaction, these substances increase the intensity of the light emission by several orders of magrntude and reduce the background light emission from the luminol-peroxide assay reagent (blank). This leads to a dramatic increase in the signal-to-blank ratio: e.g., in the presence of p-iodophenol, the signal-to-blank ratio for detection of HEP is increased several thousand-fold over the reaction in the absence of the enhancer. The light emission from this reaction is a long-lived glow (>30 mm); therefore, a precise incubation period or the addition of a stopping reagent is unnecessary because of the stability of the signal. Usually an instantaneous light intensity measurement is made between 2 and 30 mm after initiation of the reaction. A CL assay of HRP, involving a dioxetane (HMPPD) (Figure 1, structure 12) , has been disclosed in the patent literature (72). HRP cleaves the molecule to liberate 2-methylnaphthylquinone and AMPPD. The AMPPD is then quantified via an alkaline phosphatase-catalyzed CL decomposition of AMPPD (Table 3) .
A BL assay is also available for HRP. However, despite its reported high sensitivity, its application has been limited, owing to the restricted availability of Pholas dactyl us luciferin (Table 3 
) (105).
Invertase. A CL assay of this enzyme label, based on a lucigenin indicator reaction, is outlined in Table 3 . The detection limit for this assay is 740 ainol, and some preliminary reports discuss the development of enzyme 
Nonseparation (Homogeneous) Assays
Early studies showed that the light emission from an isoluminol conjugate could be enhanced when the conjugate was bound to a specific antibody or binding protein (e.g., isoluminol-biotin:avidin) (76, 77) . Specific binding reactions also modifr the kinetics of light emission from isoluminol conjugates, e.g., aminopentylethylisoluminol-cortisol and estradiol conjugates (77, 78) .
This modulation has been used effectively for numerous assays of serum and urinary steroids (79) (80) (81) . A novel homogeneous DNA probe hybridization assay has been devised, based on the use of an acridinium ester derivative (Figure 3) . The assay exploits the resistance of the bound label to hydrolysis (85 
